Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01075776
Other study ID # 007143
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date January 2020
Est. completion date January 2023

Study information

Verified date May 2020
Source Queen Mary University of London
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To determine the effects of whether increasing CNP concentrations slightly above normal will improve the functioning of blood vessels after the interruption in the flow of blood. In this study we are looking at the function of the blood vessels of the forearm, as a substitute for those in the heart


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 2023
Est. primary completion date January 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Healthy human volunteers on no systemic medication, excepting the oral contraceptive pill

Exclusion Criteria:

- History of medical illness

- Unwillingness to sign consent form

- Use of non-OCP medications

- Hypertension on examination of the blood pressure

Study Design


Related Conditions & MeSH terms

  • Ischaemia-reperfusion (IR) Injury
  • Ischemia

Intervention

Drug:
C-type natriuretic peptide (CNP)
360 pmol/min for 15 minutes intra-arterially
Saline
Sodium Chloride 0.9% intra-arterially 0.5ml/min
Acetylcholine
2 stepped infusions for a total 9min per limb, totalling 1.05micromoles per limb

Locations

Country Name City State
United Kingdom Queen Mary University London London

Sponsors (2)

Lead Sponsor Collaborator
Queen Mary University of London University College, London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in area under curve dose-response to acetylcholine after IR injury 2h